Abstract library

6 results for "Yalchin".
#1106 Salvage Treatment with Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Advanced VIPomas and Severe Verner-Morrison Syndrome
Introduction: PRRT is an effective treatment option for advanced Neuroendocrine Tumours
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: Dr Mehmet Yalchin
Keywords: PRRT VIP
#1126 Long-Term Follow-Up and Survival Data in Progressing Advanced Midgut Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy
Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an effective treatment option for advanced Neuroendocrine Tumours (NET), however long term survival data is lacking.
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr Mehmet Yalchin
Keywords: PRRT, PFS, OS
#1134 Role of Cytoreductive Surgery (CRS) and Intraoperative Hyperthermicintraperitoneal Chemotherapy (HIPEC) for High Grade Neuroendocrine Tumour
Introduction: Managing patients with omental and peritoneal Nueroendocrine tumour is challenging.
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: Dr Mehmet Yalchin
Keywords: CRS HIPEC NET
#1135 The Role of External Beam Radiotherapy in the Management of Advanced Neuroendocrine Tumors
Introduction: Palliative external beam radiotherapy (EBRT) is routinely used to control symptoms and disease progression in metastatic malignancies, but there is limited data in metastatic neuroendocrine tumours (NET).
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Others
Presenting Author: Dr Mehmet Yalchin
Keywords: EBRT, NET
#1242 Epidemiological Characteristics from a Single Centre Database. Cohort of 1301 Neuroendocrine Tumor Patients: Is There an Association Between Age and Grade of NET?
Introduction: There is limited data related to epidemiology of NETs and patient survival. For many cancers younger age of diagnosis can be associated with worse survival.
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr Mehmet Yalchin
Keywords: Survival
#1814 Predictors of Outcome in Patients Treated with Peptide Radio-Labelled Receptor Target Therapy (PRRT)
Introduction: The efficacy of PRRT has been demonstrated in patients with well differentiated NETS. The NETTER-01 study demonstrated disease stabilisation or partial response in approximately 80% of patients. However, more studies are needed to identify predictors of response
Conference: 14th Annual ENETS conference (2017)
Category: PRRT-Ablative therapies- Endoscopic treatment, surgical treatment
Presenting Author: Georgios Demetriou
Keywords: PRRT, Y90, Lu-177